Location: Home
  • search
  • go
  • Relate News
  • 10/21/2016Zai Lab Picks Up Two GSK Anti-Inflammatory Assets
  • 10/21/2016MicuRx Initiates Phase 3 Trial for New Potent Oral Antibiotic MRX-I
  • 10/20/2016Upcoming Event: International Conference and Exhibition on Nanomedicin...
  • 10/20/2016India Agitated by Large Scale API Import from China, Calling to Raise ...
  • 10/20/2016Recent Executive Moves
  • 10/20/2016Hisun Pharma Gets ANDA Approval from the USFDA
  • 10/20/2016New Study - Asia Pacific Breast Cancer Market to Grow at CAGR of 8.5% ...
  • 10/20/2016Critical Illness Insurance Now Covers 1.05 Bln Urban and Rural Residen...
  • 10/19/2016CFDA Solicits Public Comments on Biochemical Drug Appendix of GMP
  • 10/18/2016CStone's Files IND for PD-L1 Monoclonal Antibody with the CFDA
  • 10/18/2016How To Think About China's Special Economic Zones As A Foreign Pharmac...
  • 10/18/2016CFDA Solicits Public Comments on Three Appendices of GSP
  • 10/18/2016CFDA Solicits Public Comments on Cleanup of Past Official Documents
  • 10/18/2016Zhejiang and Shaanxi Relaxes Non-Essential Drug Inventory Limit in Pri...
  • 10/18/2016Guangdong Introduces New Action Plan for Healthcare Cost Containment
  • 10/17/2016Hua Medicine Announces First-Ever Successful Phase II Monotherapy Tria...
  • 10/17/2016TOT Biopharma Begins Phase II Construction of Its mAb Facility in Suzh...
  • 10/17/2016Fujifilm to Invest HK$806M in China Resources Pharma
  • 10/17/2016GSK Ramps Up Neuroscience R&D in China Thru Local Partnerships
  • 10/14/2016NHFPC, MOF Issue Official Notice to Link Negotiation Outcome and NRCMS...
  • 10/14/2016Data Snapshot: Urban Public Hospital Market for Chemical Drugs
  • 10/14/2016National Cancer Center Releases Official Chinese Cancer Prevalence Dat...
  • 10/14/2016Five Central Government Agencies Issues Two Health Science & Techn...
  • 10/14/2016Novartis Cuts More R&D Jobs, Closing Chinese and Swiss Locatio...
  • 10/13/2016Kymab, EpimAb Enter Multi-Target, Bispecific Antibody Cross-Licensing ...
  • 10/13/2016Green Cross Refocuses on China As It Halts US Trials of Hemophilia Dru...
  • 10/13/2016TransThera Biosciences Raises $10M in Round A to Develop Novel NCE Dru...
  • 10/13/2016FDA Bans Import from Another Chinese Drug Manufacturer
  • 10/13/2016Certara Establishes Phoenix PK/PD Centers of Excellence in China and J...
  • 10/13/2016Recent Executive Moves
  • Page:331/720 Total number of articles:21594: [First][<<] [329] [330] [331] [332] [333] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group